UBS Group’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4K | Sell |
7,665
-5,629
| -42% | -$22.3K | ﹤0.01% | 6845 |
|
|
2025
Q1 | $92.8K | Sell |
13,294
-11,587
| -47% | -$80.9K | ﹤0.01% | 5828 |
|
|
2024
Q4 | $365K | Buy |
24,881
+22,221
| +835% | +$326K | ﹤0.01% | 4898 |
|
|
2024
Q3 | $50.9K | Buy |
2,660
+553
| +26% | +$10.6K | ﹤0.01% | 5611 |
|
|
2024
Q2 | $37.1K | Buy |
+2,107
| New | +$37.1K | ﹤0.01% | 5768 |
|